PETS

PETMED EXPRESS INC PETS

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,774 of 2,925

Why it scores 18Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$41.02M

Quarter to Jun 30

Net income

$-6.14M

Quarter to Jun 30

Free cash flow

$-8.33M

Quarter to Jun 30

Operating margin

-15.2%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$8.92M total
RENAISSANCE TECHNOLOGIES LLC
$2.17M-4.6%
VANGUARD CAPITAL MANAGEMENT LLC
$1.59M-0.5%
BlackRock, Inc.
$1.09M+3.0%
FEDERATED HERMES, INC.
$407.4K-68.2%
GEODE CAPITAL MANAGEMENT, LLC
$391.9K-7.9%
STEEL PARTNERS HOLDINGS L.P.
$371.8K0.0%
UBS Group AG
$265.6K-40.8%
PRICE T ROWE ASSOCIATES INC /MD/
$250.0K+8.2%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$232.4K-8.8%
Rangeley Capital, LLC
$232.3K+10.8%
VANGUARD FIDUCIARY TRUST CO
$212.1K+0.7%
STATE STREET CORP
$201.9K0.0%
Formidable Asset Management, LLC
$195.1K-18.7%
Empowered Funds, LLC
$158.1K+9.8%
TUDOR INVESTMENT CORP ET AL
$156.3KNew
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$152.6K-37.3%
CITADEL ADVISORS LLC
$142.3K-15.7%
DIMENSIONAL FUND ADVISORS LP
$115.8K-71.0%
UMB Bank, n.a.
$115.2K0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$91.6KNew
NORTHERN TRUST CORP
$81.9K-9.4%
XTX Topco Ltd
$80.5KNew
SIMPLEX TRADING, LLC
$47.7KNew
IMC-Chicago, LLC
$44.0KNew
Jain Global LLC
$26.1KNew
See all 50 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q1 2027
EDGAR

Net Income

Q1 2027
EDGAR

EPS (Diluted)

Q1 2027
EDGAR

Operating Margin

Q1 2027
EDGAR

Free Cash Flow

Q1 2027
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PETS

Earnings Per Share

13fpro.ai/company/PETS

Loading ratio trend…

PETS key financials by period

Reported revenue, net income and operating margin by fiscal year, from PETMED EXPRESS INC's annual filings on SEC EDGAR.

PETMED EXPRESS INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2026$179.0M$-57.3M-32.8%
FY 2025$227.0M$-6.3M-0.7%
FY 2024$274.1M$-7.5M-3.0%
FY 2023$247.6M$5.1M2.4%
FY 2022$272.3M$18.7M8.9%
FY 2021$303.6M$23.9M10.1%
Source: PETS filings on SEC EDGAR →

Companies similar to PETS

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

PETS insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About PETMED EXPRESS INC (PETS): stock profile, AI score and financials

PETMED EXPRESS INC (PETS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PETS at 18.1/100 on a composite quality score built from its SEC filings, placing it at rank #2,774 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (3.9) and institutional flow (4.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2027), PETMED EXPRESS INC reports quarterly revenue of $41.0M, net income of $-6.1M, an operating margin of -15.2%. Top institutional holders of PETS by reported 13-F value include RENAISSANCE TECHNOLOGIES, VANGUARD CAPITAL MANAGEMENT, BlackRock, based on the most recent SEC filings. PETS trades on the Nasdaq exchange and files with the SEC under CIK 1040130. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PETS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PETMED EXPRESS INC directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1040130 →